Gelomyrtol Forte 2x20 Capsules

Product Information

Yu PJ, Wan LM, Wan SH, Chen WY, Xie H, Meng DM, etal. (December 2016). "Standardized myrtol attenuates lipopolysaccharide induced acute lung injury in mice". Pharmaceutical Biology. Taylor & Francis, Informa Healthcare. 54 (12): 3211–3216. doi: 10.1080/13880209.2016.1216132. PMID 27569254. S2CID 40769496.

Indications: GeloMyrtol Forte is a herbal medicine, the active substance is obtained from the essential oils of plants. For liquefying secretions in case of sinusitis and bronchitis. You must talk to a doctor if you do not feel better or if you feel worse after 10 days. The special distillate contained in Gelo Myrtol 300 mg capsulesactivates the natural clearing of the airways. It liquefies viscous mucus and stimulates the glands to produce thin fluid secretion. The authors thank TopEdit ( www.topeditsci.com) for its linguistic assistance during the preparation of this manuscript. Author contributions Thomas Wittig: GeloMyrtol forte standardised – A clinical documentation. 4th edition, 2005, Ergebnisse-Verlag, ISBN 978-3-87916-067-9 Išgrynintų eukaliptų, saldžiųjų apelsinų, mirtų ir citrinų eterinių aliejų mišinio (66:32:1:1) distiliatas

4. Gelomyrtol forte sudėtis

Prodaja ovog leka zabranjena je putem interneta zakonom Republike Srbije , dok je oglašavanje istog putem interneta dozvoljeno isključivo kao podsetnik i ima svrhu informisanja. Allergies to eucalyptus oil, sweet orange oil, myrtle oil or lemon oil as well as cineol, the main component of eucalyptus oil, exclude the use of gelomyrtol. More tips for using the expectorant GeloMyrtol Gelomyrtol/Gelomyrtol forte kapsulės geriamos 30 min. prieš valgį, užgeriant pakankamu kiekiu šalto skysčio. Paskutinioji dozė gali būti geriama prieš pat miegą.

Atidžiai perskaitykite visą šį lapelį, prieš pradėdami vartoti šį vaistą, nes jame pateikiama Jums svarbi informacija. To facilitate expectoration in the morning in cases of chronic bronchitis:take 2 additional capsules of GeloMirtol before bedtime.Trys pagrindinės medžiagos daugiausiai pašalinamos su šlapimu metabolitų pavidalu. Dalis iškvėpiama. For chronic diseases: take 2 capsules x 3 times a day - the recommended dosage for maintenance therapy.

GeloMyrtol forte ima mukosekretolitičko (razvodnjava gust sekret) i sekretomotoričko (stimuliše pokretanje sekreta) dejstvo. Pomaže u iskašljavanju i deluje antiinflamatorno.In a post-hoc analysis of the study, patients with chronic bronchitis and simultaneously suffering from COPD (chronic obstructive pulmonary disease) were investigated. 64 patients met this criterion. Even for those patients with COPD, ELOM-080 reduced the number of exacerbations during the winter season. The number of patients with at least one exacerbation was statistically significantly smaller than under the sham treatment (29% vs. 55%). The patients felt much less impaired by coughing and sputum under the therapy with ELOM-080, and they evaluated their state of health more often as good or very good in comparison with a sham therapy. [38] [36] [39] In this connection, both treatments had comparable tolerability.

Upozorite lekara ako uzimate druge lekove, imate neku hroničnu bolest, neki poremećaj metabolizma, preosetljivi ste na lekove ili ste imali alergijske reakcije na neke od njih. We will use a funnel plot to assess the reporting bias if ten or more studies are included. [23] 2.5 Data synthesis GeloMyrtol® forte (DE) is a registered trade mark [44] used to designate an herbal medicinal product to combat acute and chronic bronchitis and sinusitis. The finished medicinal product contains 300mg of ELOM-080 active ingredient. Smaller capsules with an active ingredient content of 120mg contain the medicinal product Myrtol® for administration to children from the age 6 years on. ELOM-080 has been used for decades and has been tested in clinical studies. Randomised, double-blind, placebo-controlled multi-centre studies according to the international GCP standard ( Good clinical practice) have been conducted, with the objective of proving the efficacy and tolerability according to the principles of evidence-based medicine. These clinical studies have been supplemented by non-interventional studies. ir šunims ilgai (26 savaites) skiriant išgrynintų eukaliptų, saldžiųjų apelsinų, mirtų ir citrinų eterinių aliejų mišinio distiliato , histopatologinio toksiškumo, kuris galėtų daryti įtaką žmonėms, nenustatyta. Didelių geriamojo išgrynintų eukaliptų, saldžiųjų apelsinų, mirtų ir citrinų eterinių aliejų mišinio distiliato dozių farmakologiniais saugumo tyrimais nustatytas poveikis atitinka jau žinomą eterinių aliejų poveikį.

3. Kaip vartoti Gelomyrtol forte

In a randomised, double-blind, placebo-controlled study with 246 patients with chronic bronchitis, the long-term treatment over 6 months with ELOM-080 was investigated in comparison with placebo. In the process, ELOM-080 proved to be superior to placebo as regards effect: The intensity and frequency of acute deteriorations (exacerbations) of the chronic bronchitis were reduced statistically significantly and to a relevant extent with ELOM-080. By virtue of the treatment, an exacerbation peak that is typical of the season for the placebo group between the 2nd and 4th treatment month (usually December to February) did not occur in the ELOM-080 group. [35] [36] The quality of life of the patients, assessed according to their general condition and their impairment by coughing and sputum expectoration, was statistically significantly improved by the therapy with ELOM-080. Moreover, the need for antibiotics was clearly reduced under ELOM-080 in comparison with the sham treatment. In the process, ELOM-080 proved just as tolerable as placebo. The study has been considered by the Cochrane Airways Group in their annual review of the theme of mucolytics vs. placebo in chronic bronchitis and COPD. [37] We will use χ 2 tests to evaluate the statistical heterogeneity in the forest plot by RevMan V.5.3. According to the Cochrane Handbook, P values <0.1 will be identified as significant. [23] Furthermore, I 2 values will be analyzed to quantify the influence of the statistical heterogeneity. Heterogeneity will be classified into 4 categories according to the Cochrane Handbook as follows: 0% to 40%, might not be important; 30% to 60%, indicates moderate heterogeneity; 50% to 90%, represents substantial heterogeneity; and 75% to 100%, suggests considerable heterogeneity. 2.4.8 Assessment of reporting biases Visada vartokite šį vaistą tiksliai kaip nurodė gydytojas arba vaistininkas. Jeigu abejojate, kreipkitės į gydytoją arba vaistininką.